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ransendothelial migration of monocytes is the process
by which monocytes leave the circulatory system and
extravasate through the endothelial lining of the
blood vessel wall and enter the underlying tissue. Transmi-
gration requires coordination of alterations in cell shape
and adhesive properties that are mediated by cytoskeletal
dynamics. We have analyzed the function of RhoA in the
cytoskeletal reorganizations that occur during transmigra-
tion. By loading monocytes with C3, an inhibitor of RhoA,
we found that RhoA was required for transendothelial mi-
gration. We then examined individual steps of transmigra-
tion to explore the requirement for RhoA in extravasation.
Our studies showed that RhoA was not required for mono-
T
 
cyte attachment to the endothelium nor subsequent spread-
ing of the monocyte on the endothelial surface. Time-lapse
video microscopy analysis revealed that C3-loaded mono-
cytes also had signiﬁcant forward crawling movement on
the endothelial monolayer and were able to invade between
neighboring endothelial cells. However, RhoA was required
to retract the tail of the migrating monocyte and complete
diapedesis. We also demonstrate that p160ROCK, a serine/
threonine kinase effector of RhoA, is both necessary and suf-
ﬁcient for RhoA-mediated tail retraction. Finally, we ﬁnd
that p160ROCK signaling negatively regulates integrin ad-
hesions and that inhibition of RhoA results in an accumula-
 
tion of 
 
 
 
2 integrin in the unretracted tails.
 
Introduction
 
Cells receive information about their surroundings through
physical contacts with other cells or the extracellular matrix.
Points of contact are mediated by transmembrane adhesion
molecules that are linked to the intracellular cytoskeleton. In
addition to their structural function, these adhesion sites
serve as a platform for the assembly of signaling complexes
that relay information about the surrounding environment
(Critchley, 2000; Sastry and Burridge, 2000). A critical tar-
get of signals induced by cell–matrix interactions is the cy-
toskeleton itself. The structure of the cytoskeleton is highly
malleable making it well-suited to respond to extracellular
stimuli. Numerous studies have implicated the Rho family
of small GTPases (including RhoA, Rac1, and Cdc42) as
key modulators of the cytoskeletal dynamics that occur af-
ter a cell adhesion event (Hall, 1998; Kaibuchi et al.,
1999; Tanaka and Takai, 1998; Schoenwaelder and Bur-
ridge, 1999). Our previous work has addressed cytoskeletal
changes that result from either fibroblast adhesion to extra-
cellular matrix or epithelial cell–cell interactions. Here, we
describe studies that examine the function of RhoA in mod-
ulating cytoskeletal events that result from contact between
two different cell types: monocytes and endothelial cells.
Monocyte binding to activated endothelium triggers a series
of alterations in monocyte shape and adhesive properties
necessary for its transmigration though the blood vessel wall
to reach the underlying tissue (Butcher, 1991; Butcher and
Picker, 1996; Ebnet et al., 1996; Brown, 1997).
The function of Rho GTPases has been most extensively
studied in fibroblasts. Migration of fibroblasts is thought to
occur by lamellipodial extensions at the leading edge of a po-
larized cell followed by strengthening of adhesions at the
front of the cell and dissolution of adhesion at the rear of the
cell (Stossel, 1993; Mitchison and Cramer, 1996; Lauffen-
burger and Horwitz, 1996). Rho GTPases are critical for the
cell shape changes and adhesion dynamics that drive migra-
tion (Nobes and Hall, 1995, 1999; Clark et al., 1998; Woj-
ciak-Stothard et al., 1998; Erickson and Cerione, 2001).
Cdc42 is required for cell polarity and stimulates filopodial
protrusions, whereas Rac1 promotes lamellipodial exten-
sions rich in filamentous actin. A basal level of RhoA is
needed for fibroblast migration, although too much RhoA
activity impedes migration (Takaishi et al., 1994; Ridley et
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al., 1995; Nobes and Hall, 1999). Unrestrained RhoA activ-
ity may stimulate a particularly high cortical tension barrier
at the leading edge, as well as lead to excessive adhesion
through focal adhesions. The requirement of RhoA activity
for migration is thought to stem from the need for traction
provided by RhoA-stimulated integrin adhesions and acto-
myosin-based contractility to pull up the rear of the cell. In-
terestingly, a recent study has shown that an effector of
RhoA, p160ROCK, is required for tail retraction of prostate
cancer cells (Somlyo et al., 2000).
Adherent fibroblasts and circulating leukocytes have dra-
matically different cytoskeletal structure in the resting state,
preventing direct translation of results from experiments of
fibroblasts to leukocytes. Nonetheless, some of the effects of
Rho GTPases on leukocyte cytoskeletal alterations during
adhesion are similar to those observed in fibroblasts. Cdc42
and Rac1 regulate cell polarity, lamellipodial extensions, and
directed migration in cultured leukocytes (Allen et al., 1997,
1998; del Pozo et al., 1999). In addition, Cdc42-mediated
cytoskeletal changes have been shown to be necessary for
transendothelial migration of monocytes in a cell culture sys-
tem (Weber et al., 1998). In leukocytes, inhibition of RhoA
potentiates spreading, an effect likely due to relief of cortical
tension and disruption of the circumferential actin network
surrounding the cell that are required to maintain a rounded
morphology (Weber et al., 1998; Watson et al., 2000). The
role of RhoA in leukocyte adhesion remains controversial
and has distinct differences from adherent cells where RhoA
clearly promotes the formation of integrin-containing adhe-
sion complexes. Some studies have shown that RhoA is re-
quired for integrin-mediated adhesion in leukocytes, whereas
others have shown that RhoA inhibits adhesion (Tominaga
et al., 1993; Aepfelbacher, 1995; Aepfelbacher et al., 1996;
Laudanna et al., 1996; Anderson et al., 2000). The function
of RhoA in adhesion has also been reported to depend on the
substrate used in the adhesion assay (Petruzzelli et al., 1998). It
has been proposed that in resting leukocytes, integrins are held
inactive by tethering to the actin cytoskeleton, but that sub-
sequent reattachments are formed for optimal function
(Kucik et al., 1996; Lub et al., 1997; Sampath et al., 1998;
Stewart et al., 1998). It has been suggested that this dual role
for the cytoskeleton in regulation of integrin-mediated adhe-
sion accounts for some of the reported discrepancies for the
function of RhoA in leukocyte adhesion.
The Rho family of small GTPases has been implicated in
regulating leukocyte function during immune system re-
sponses in vivo. Recently, a human neutrophil immunodefi-
ciency syndrome has been attributed to an inactivating
mutation of the Rac2 gene, and is consistent with the immu-
nodeficiency phenotype observed in Rac2 null mice (Rob-
erts et al., 1999; Ambruso et al., 2000). Cdc42 has been im-
plicated in inflammation through its regulation of the
protein found to be defective in the Wiskott-Aldrich syn-
drome (WAS).* WAS is characterized by immunodefi-
ciency, eczema, and thrombocytopenia, and the WAS pro-
tein is required for both lymphocyte proliferation, microvilli
formation, and chemotaxis (Zicha et al., 1998; Snapper and
Rosen, 1999). p160ROCK (also known as ROK or Rho Ki-
nase) is a serine/threonine kinase important for RhoA sig-
naling and is reported to modulate the accumulation of
macrophages in arterial lesions in a porcine model for
arteriosclerosis (Miyata et al., 2000).
Similar to leukocyte extravasation, the process of tumor
cell metastasis requires cells to cross the endothelial lining of
vessel walls. The Rho GTPases have been linked to tumor
cell invasion and metastasis in several different systems.
Tiam-1 was cloned in a screen designed to identify genes
that confer invasive potential to noninvasive T-lymphoma
cells, and was subsequently found to be an activator of Rac1
(Habets et al., 1994; Michiels et al., 1995). Using DNA mi-
croarrays to compare a matched pair of noninvasive and
metastatic melanoma cell lines, RhoC was identified as one
of the molecules upregulated during the transition to malig-
nancy. Furthermore, the authors showed that dominant
negative RhoA was able to block matrigel invasion by the
metastatic cell line (Clark et al., 2000). Both RhoA and
p160ROCK have been implicated in tumor cell invasion
and metastasis. Rat hepatoma cells invade a cultured mono-
layer of mesothelial cells in a manner dependent on RhoA
and p160ROCK (Yoshioka et al., 1998; Imamura et al.,
1999; Itoh et al., 1999). Significantly, in vivo mouse models
of metastasis suggest that RhoA and p160ROCK promote
metastasis (del Peso et al., 1997; Itoh et al., 1999).
Our studies were designed to determine how modulation
of cell morphology and adhesion by Rho GTPases regulate
transendothelial migration. We have focused on the effects
of RhoA on cell adhesion and migration stimulated by
monocyte adhesion to activated endothelial cells in a cell
culture system. We report that monocytes required RhoA to
efficiently execute transendothelial migration because RhoA
activity was necessary to retract the rear of the cell. Further-
more, we found that the p160ROCK signaling pathway is
both necessary and sufficient for retraction of the tail in mi-
grating monocytes. We also present data that suggest the
mechanism of RhoA/p160ROCK–mediated tail retraction
is through negative regulation of integrin-mediated adhe-
sions at the rear of the cell.
 
Results
 
Transendothelial migration of monocytes 
requires RhoA
 
To study the interaction between monocytes and endothe-
lial cells, we first optimized a transmigration assay (see Mate-
rials and methods for details). Primary human umbilical
vein endothelial cells (HUVECs) were seeded on transwells
at a confluent density 3 d before the assay. The HUVECs
were stimulated with the inflammatory cytokine, IL-1, over-
night to activate the endothelial cells and upregulate the sur-
face expression of cell adhesion molecules crucial for mono-
cyte adhesion. Either primary monocytes or THP-1 cells, a
monocytic cells line, were added to the upper chamber and
allowed to transmigrate for 1 or 3 h, respectively. The num-
ber of cells that crossed the endothelial monolayer were
 
*Abbreviations used in this paper: BDM, 2,3-butanedione monoxime;
GST, glutathione 
 
S
 
-transferase; HUVEC, human umbilical vein endo-
thelial cell; LPS, lipopolysaccharide; MLCK, myosin light chain kinase;
RBD, RhoA binding domain; WAS, Wiskott-Aldrich syndrome. 
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counted, and the results were plotted in Fig. 1 A. The pres-
ence of the chemokine MCP-1 in the lower chamber in-
creased the number of primary monocytes and THP-1 cells
that transmigrated. These results show that our cell culture
system supported transendothelial migration and was suit-
able for studying the function of the monocyte cytoskeleton
during this process. To assess the requirement of RhoA in
transmigration, we electroporated C3 exoenzyme into pri-
mary monocytes immediately after their isolation. C3 treat-
ment resulted in decreased RhoA activity, but had no affect
on the activity of Rac1 or Cdc42 as determined by affinity
precipitation assays (data not shown) (Bagrodia et al., 1998).
Fig. 1 B shows that transmigration of cells electroporated
with C3 was only 34% as efficient as control cells electropo-
rated with glutathione 
 
S
 
-transferase (GST).
 
Initial attachment of monocytes to the endothelium 
does not require RhoA
 
Transmigration was divided into three distinct steps that
could be measured experimentally. First, cells adhere to the
endothelium through a wide range of molecular interactions
including glycoproteins, Ig-containing adhesion molecules,
and integrins. Second, leukocytes spread into a more flat-
tened morphology and extend membrane to migrate along
and invade between neighboring endothelial cells. Finally,
cells complete diapedesis through the endothelial monolayer
to reach the underlying tissue. Thus, we asked which step of
transmigration required RhoA activity. To measure the ini-
tial attachment of monocytes to endothelial monolayers, the
number of monocytes per field that were adherent at 15 min,
were counted by microscopy. Because the surface expression
of many endothelial adhesion molecules requires activation
of inflammatory cytokines, we compared the adhesion of
monocytes to resting or activated monolayers. Fig. 2 shows
that activation of endothelial cells with IL-1 increased the
adhesion of monocytes 
 
 
 
10-fold. We found that inhibition
of RhoA by C3 loading had no effect on the ability of mono-
cytes to adhere to either resting or activated endothelium.
 
Inhibition of RhoA does not block spreading,
but results in abnormal morphology
 
We next explored the requirement for RhoA in monocyte
spreading. First, we examined the actin cytoskeleton of cells
loaded with either GST or C3, when plated on coverslips in
serum-free medium. We observed profound morphological
effects in cells treated with C3. The dramatic effect on mono-
cyte morphology was observed as early as 15 min, and as late
as 2 h after plating (data not shown). Although control cells
adhered to the glass, but remained rounded, the C3-loaded
cells spread and appeared to have long tails (Fig. 3 A). The
F-actin in leukocytes accumulated in membrane ruffles and
small punctate structures called podosomes (Marchisio et al.,
1987). Actin polymerization at the leading edge is thought to
drive forward movement of the cell, whereas podosomes con-
tain many of the same proteins found in focal adhesions such
as talin and vinculin. To further examine the organization of
the cytoskeleton, we plated cells in the presence of serum to
enhance spreading and migration. In addition, we assessed
both the microtubule and actin structures. The microtubule
network is an important cytoskeletal component that controls
cell morphology, and its regulation is intimately tied to that
of the actin cytoskeleton and Rho GTPases (Gundersen and
Cook, 1999; Waterman-Storer et al., 1999; Ishizaki et al.,
2001). The immunofluorescence micrographs in Fig. 3 B re-
vealed that the core of the monocyte is filled with a microtu-
bule network and that F-actin was prominent at the cell pe-
riphery. In sharp contrast, the C3-loaded cells were frequently
polarized and appear to have long tails trailing behind the cell
body. Note that there is a wide range of severity of this phe-
notype, but in all extended tails there is a significant microtu-
bule network. In addition, we frequently observed prominent
actin rich membrane protrusions in the tail.
To verify that the phenotype observed with C3 was due to
its affect on RhoA, we used another means to inhibit RhoA in
monocytes. We introduced the RhoA binding domain (RBD)
Figure 1. (A) Transendothelial migration of monocytes is en-
hanced by MCP-1. The number of monocytes that transmigrated 
through an IL-1 activated, and endothelial monolayer increased 
more than fivefold for THP-1 cells and twofold for primary mono-
cytes when MCP-1 was present in the lower chamber of a transwell 
chamber. The average number of transmigrated cells per field is 
plotted as the average from three separate experiments. (B) RhoA is 
required for transendothelial migration of monocytes. Transendo-
thelial migration of primary monocytes electroporated with C3 is 
plotted as a percent of transmigration activity achieved by mono-
cytes loaded with GST (control). 
150 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, 2001
 
from Rhotekin by electroporation and examined the morphol-
ogy of the cells by F-actin staining (Fig. 3). RBD binds to the
effector domain of GTP-bound RhoA and is predicted to pre-
vent its adhesion to downstream signaling partners. An analo-
gous technique with the effector binding domain from Cdc42
has been used to block the function of WASp
 
 
 
(Haddad et al.,
2001). We found that monocytes loaded with RBD exhibited
a phenotype similar to that observed by loading with C3. We
believe that the C3 phenotype is more severe than that ob-
served with RBD because of differences in the mechanism of
RhoA inhibition. C3 inhibits RhoA by covalent modification
of the effector domain, whereas inhibition by RBD is accom-
plished by competition with effectors. This is further evidence
that the effect of C3 is specifically on RhoA.
Next, we examined the morphology of monocytes cocul-
tured with activated endothelial cells. The monocytes were
plated on endothelial monolayers cultured on coverslips and
stimulated with IL-1 overnight. To easily distinguish the
monocytes from the endothelial cells, we labeled primary
monocytes with Cell Tracker™ green, which fills the cyto-
plasm with fluorescent dye. Thus, the fluorescence micro-
graphs in Fig. 4 A only show the morphology of the mono-
cytes in the coculture samples. The GST-loaded control cells
assumed a triangular morphology with a short tail when mi-
grating across the top of the endothelial monolayer. The po-
sition of the monocyte relative to the endothelial monolayer
was determined by adjusting the focal plane during micro-
scopic analysis. Once the monocyte had transmigrated un-
derneath the monolayer, it assumes a more spread pheno-
type. Similar to the morphology observed on glass coverslips,
C3-loaded monocytes appear to have long trailing tails ex-
tending from the main cell body. Even though only the
monocytes are labeled, the three-dimensional nature of these
cells plated on HUVECs was observed in this type of analy-
sis. To visualize both cell types, we stained the cocultures for
F-actin. As judged by analysis of the focal plane, the majority
of the GST-loaded monocytes shown in Fig. 4 B were un-
derneath the HUVEC monolayer and had a well-spread
morphology with multiple actin-rich membrane protrusions.
 
The C3-loaded monocytes were rarely found spread under-
neath the monolayer. In fact, the monocytes often accumu-
lated around the periphery of an endothelial cell, with part of
the monocyte spread underneath the monolayer and the rest
of the monocyte on the top of the monolayer (Fig. 4 B).
 
RhoA is required for tail retraction but not forward 
movement or monolayer invasion
 
Inhibition of RhoA by C3 has been described to cause mem-
brane extensions that bear some resemblance to structures
we observe in our monocytes (Allen et al., 1997; Kozma et
al., 1997). To determine if the phenotype we observed in
fixed cells was indeed a failure to retract the tail and not un-
regulated protrusions, we examined the movement of the
monocytes on endothelial monolayers by video microscopy.
Fig. 5 is a series of individual frames that show the move-
ment of either GST-loaded (Fig. 5 A) or C3-loaded (Fig. 5
B) cells. The time elapsed between frames 1 and 6 is 6 min.
The GST-loaded cell shown was migrating across the top of
the endothelial monolayer, showing movement driven by
lamellipodial extension at the leading edge, followed by re-
traction of the rear of the cell. For brief periods of time, con-
trol cells were observed to possess a short tail. In contrast,
the sequence of C3-loaded cells shows a cell with a long tail
and a main cell body that easily moves forward, but com-
pletely lacks tail retraction. Despite the forward crawling ac-
tivity exhibited by the C3-loaded cell, the failure to retract
the tail appears to draw the cell back to its starting point,
eliminating any net translocation of the cell.
The full time-lapse video recorded the movement of mono-
cytes over a 20-min period, with a frame taken every 15 sec-
onds. Video 1 clearly shows GST-loaded control cells transmi-
grating between neighboring endothelial cells and continuing
to exhibit robust membrane activity and migration under-
neath the monolayer. Video 2 of C3-loaded cells shows two
cells that migrate on the top of the endothelial surface the dis-
tance of several cell body lengths but never retract the tail and
result in elongated cells with pronounced tails. The behavior
of the cells was indicative of failure to release adhesions made
at the rear. The other two cells in the video sequence success-
fully invaded the monolayer and had vigorous membrane
activity but did not complete diapedesis. We used image
analysis to measure forward movement of the monocytes.
Individual cells were monitored by tracing the outline of a cell
for 15 consecutive frames (representing 5-min elapsed time),
and the movement of the x/y center of the cell was plotted.
By measuring cell movement over this short period of time,
this analysis reflects forward movement of a cell, even if a long
tail is left behind. Fig. 5 C shows that inhibition of RhoA did
not affect the forward motility of the monocytes. Total dis-
tance moved in this brief time period ranged from 20–30
 
 
 
m, or 2–3 cell body lengths. Time-lapse video is available at
http://www.jcb.org/cgi/content/full/200103048/DC1.
Next, the time-lapse videos were evaluated to determine
the number of cells that were able to invade the monolayer,
and to complete passage through the monolayer. In the con-
trols, we observed two populations of monocytes, some that
migrated very quickly only across the top of the endothe-
lium, whereas others transmigrated through the monolayer.
Figure 2. RhoA is not required for adhesion to the endothelium. 
Fluorescently labeled GST- (control) or C3-loaded monocytes were 
plated onto resting or IL-1–stimulated endothelial monolayers 
grown in 96 well plates. After 15 min, the cocultures were washed 
with PBS, and adhesion of the monocytes was quantitated by mea-
suring the fluorescence. Data plotted are the average of triplicate 
wells from a typical experiment. 
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The relative proportion of cells exhibiting these two behavior
types varied with the monocyte donors. Quantitation of the
behavior of monocytes from three donors showed that 62%
of control monocytes were able to invade the monolayer, and
nearly all of those were able to complete diapedesis (Fig. 5
D). In contrast, 48% of the C3-loaded monocytes attempted
invasion, but only 18% were able to completely migrate
through the monolayer. Because inhibition of RhoA had lit-
tle effect on the percentage of cells that invaded the endothe-
lium, C3 did not appear to shift monocytes from the subset
that can transmigrate, to the subset that simply migrates
quickly along the endothelial surface. Thus, RhoA activity
played only a small role in invasion of the monolayer, but
was critical for completion of diapedesis. Together, these re-
sults demonstrate RhoA activity is required for successful tail
retraction during transendothelial migration.
 
p160ROCK is necessary and sufficient 
for RhoA-mediated tail retraction
 
To further investigate the signal transduction pathway that
leads to tail retraction, we used a specific inhibitor of
p160ROCK, Y-27632 (Uehata et al., 1997). This pharmaco-
logical reagent is reported to be specific for p160ROCK at 10
Figure 3. Inhibition of RhoA causes a 
defect in tail retraction. (A) Primary 
monocytes were loaded with GST, C3, or 
RBD and plated on coverslips in serum-
free media for 45 min before fixation and 
staining for F-actin. (B) Monocytes were 
loaded with GST, C3, or RBD and plated 
on coverslips in media containing 10% 
autologous serum for 45 min, followed 
by staining for F-actin (red) and tubulin 
(green). Bar, 20  m.
Figure 4. Morphology of monocytes 
loaded with C3 when plated on endothe-
lial cells. (A) Either GST- or C3-loaded 
monocytes were fluorescently labeled 
with CMFDA and cultured with IL-1–acti-
vated endothelial cells for 45 min before 
fixation. (B) Either GST- or C3-loaded 
monocytes were cultured with IL-1–acti-
vated endothelial cells for 45 min before 
fixation and staining for F-actin. Arrows 
indicate the location of monocytes in the 
cocultures. Bars, 20  m. 
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M (Ishizaki et al., 2000), although the possibility exists that
Y-27632 may have additional targets. p160ROCK is a serine/
threonine kinase that is activated by RhoA and has been
shown to be a critical modulator of RhoA-mediated actin
dynamics (Amano et al., 2000). To examine the role of
p160ROCK in monocyte tail retraction, we plated primary
monocytes on coverslips in the presence of 10 
 
 
 
M of Y-27632
and then stained for F-actin to visualize cell morphology. Cells
treated with the p160ROCK inhibitor showed morphological
abnormalities similar to those observed in C3-loaded mono-
cytes, albeit less severe (Fig. 6 A). The percentage of cells with
tails was quantitated over a range of Y-27632 concentrations.
We found that even at 1 
 
 
 
M, the percentage of cells with de-
tectable tails nearly doubled over controls. Both the percentage
of cells with tails, and the length of the unretracted tails in-
creased with the concentration of Y-27632 (Fig. 6 A).
To test if p160ROCK was sufficient for RhoA-mediated
tail retraction, we introduced a combination of C3 and a
constitutively active version of p160ROCK (CA ROCK) to
see if CA ROCK could block C3-induced tail formation
(Ishizaki et al., 1997). Fig. 6 B shows that cells treated with a
combination of C3 and GST formed tails, whereas cells
loaded with C3 and CA ROCK displayed few unretracted
tails. These results demonstrate that p160ROCK is the pri-
mary RhoA-mediated signaling pathway that stimulates tail
 
retraction. In addition, these results confirm that the effect of
Y-27632 on monocyte tail retraction is through p160ROCK
and not another target. Together, our results show that
p160ROCK is both necessary and sufficient to regulate tail
retraction downstream of RhoA.
Next, we wanted to determine if p160ROCK-mediated
tail retraction occurred in monocytes cocultured with HU-
VECs. The effect of inhibiting p160ROCK in monocytes
cocultured with endothelial monolayers was assessed by la-
beling monocytes with Cell Tracker™ green and fluorescent
microscopy. Monocytes treated with Y-27632 were predom-
inantly present on the cell surface and frequently had long
tails, similar to the effects of C3 treatment (Fig. 6 C). Often,
Y-27632–treated monocytes were found caught in between
neighboring endothelial cells, just as had been observed with
the inhibition of RhoA by C3. These results implicate
p160ROCK signaling pathway in RhoA-dependent tail re-
traction during monocyte transmigration.
 
Physical mechanism underlying the tail retraction defect
 
Microtubule dynamics. 
 
It has been reported that microtu-
bules are critical for retracting the rear of migrating mela-
noma cells and fibroblasts (Ballestrem et al., 2000; Kaverina
et al., 2000). Because of the presence of prominent microtu-
bules in the unretracted tails, we sought to determine if dis-
Figure 5. Time-lapse analysis of mono-
cyte movement. Monocytes loaded with 
either GST or C3 were cocultured with 
IL-1–activated endothelial monolayers, 
and video microscopy data were col-
lected. Frames were taken every 20 s for 
25 min. The sequences shown represent 
cell movement over 6.5 min. (A) GST-
treated monocytes. (B) C3-loaded mono-
cytes. (C) The movement of the x/y center 
of 10 GST- or C3-loaded monocytes was 
tracked for 15 frames. Each line repre-
sents the movement of a single mono-
cyte over a 5-min period. (D) The ability 
of monocytes to invade the monolayer or 
to complete diapedesis was quantitated 
from analysis of video sequences from 
three separate experiments. Bars, 20  m. 
Supplemental video is available at 
http://www.jcb.org/cgi/content/full/
200103048/DC1. 
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ruption of microtubule dynamics was responsible for tail re-
traction. Two approaches were taken. First, monocytes were
treated with the microtubule stabilizing drug, taxol, to deter-
mine if blocking microtubule depolymerization would pre-
vent tail retraction. Second, C3-loaded monocytes were ex-
posed to the microtubule depolymerizing agent, nocodazole,
in an attempt to rescue the tail retraction defect. Fig. 7
shows that stabilizing microtubules did not lead to the for-
mation of long tails, and that even depolymerizing the entire
microtubule network with nocodazole did not cause C3-
induced tails to retract. However, these results do not pre-
clude a role of microtubules in monocyte tail retraction, but
indicate that the C3-induced block of tail retraction must
occur downstream from microtubule dynamics.
 
Myosin-based contractility. 
 
Both RhoA and its down-
stream effector, p160ROCK, are important regulators of ac-
tomyosin-based contractility (Chrzanowska-Wodnicka and
Burridge, 1996; Kimura et al., 1996; Kureishi et al., 1997).
In addition, myosin II is reported to be localized to the rear
of migrating cells and the mechanical contractile force ex-
erted by interactions between myosin II and actin are
thought to be important for advancing the rear of the
cell during migration (Lauffenburger and Horwitz, 1996;
Sanchez-Madrid and del Pozo, 1999). Furthermore, it has
been reported that blocking contractility with inhibitors of
myosin light chain kinase (MLCK) results in unretracted
uropods (Eddy et al., 2000). The uropod is a protrusion at
the rear of polarized leukocytes that extends upwards from
the cell body and contains high levels of various adhesion
molecules which are important for mediating cell–cell in-
teractions with other leukocytes (del Pozo et al., 1999;
Sanchez-Madrid and del Pozo, 1999). To determine if in-
hibitors of actomyosin-based contractility could mimic the
C3 phenotype in our monocytes, we treated cells with either
2,3-butanedione monoxime (BDM) or ML-7 and observed
the effect on cell morphology using F-actin staining (Fig.
8). BDM inhibits myosin ATPase activity, whereas ML-7
blocks the action of MLCK. BDM treatment did not induce
tail formation, and instead the cells assumed a rounded mor-
phology and were unable to spread. Due to the severe effect
of BDM on monocyte spreading, we tried treating cells with
BDM doses ranging from 0.1 to 20 mM, but failed to ob-
serve tails at any concentration (data not shown). To cir-
cumvent the spreading defect in BDM-treated monocytes,
we added the inhibitor after cells had adhered and spread
(15 min), but still observed rounded cells and no tails were
formed (data not shown). Inhibition of MLCK by ML-7
was also not sufficient to inhibit tail retraction. At 20 
 
 
 
M
ML-7, cells were indistinguishable from controls, and at 50
 
 
 
M cells, became rounded (data not shown). In fibroblast
control cells, both 20 mM BDM and 50 
 
 
 
M ML-7 were
able to block actin stress fiber assembly (data not shown).
Figure 6. p160ROCK is both neces-
sary and sufficient for RhoA-mediated 
tail retraction. (A) Monocytes were 
plated onto coverslips in the presence of 
10% autologous serum with or without 
the p160ROCK inhibitor, Y-27632 (10 
 M). The graph represents data obtained 
from monocytes plated onto coverslips 
with serum containing media and a 1.0–
10  M range of Y-27632 for 45 min. 
Cells were then fixed, stained for F-actin, 
and the percentage of cells with tails was 
scored. The data plotted represent the 
average from three separate experiments. 
After 45 min incubation, cells were fixed 
and stained for F-actin to reveal cell 
morphology. (B) Monocytes were elec-
troporated with C3   CA ROCK and 
compared with those electroporated 
with C3   GST. Cells were plated on 
coverslips with serum-containing media 
for 45 min before fixation. Cells were 
stained for F-actin for morphological as-
sessment. (C) Fluorescently labeled 
monocytes were pretreated with 10  M 
Y-27632 for 15 min and then washed 
and added to activated endothelial 
monolayers in the presence of 1  M 
Y-27632 for 20 min before fixation. Im-
ages reveal the morphology of only the 
monocytes in the coculture. Cells on the 
left of each pair of images were on top of 
the endothelial monolayer, as judged by 
the focal plane. Cells on the right were 
underneath the monolayer (controls), or 
caught between neighboring endothelial 
cells (Y-27632). Bars, 20  m. 
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We also attempted to block the C3- or Y-27632–induced
formation of tails by stimulating contractility. Calyculin A is
a serine/threonine phosphatase inhibitor that results in the
accumulation of phosphorylated myosin and contraction
within the cell (Chartier et al., 1991). Monocytes were
treated with Y-27632 in the presence 5 nM calyculin A, a
concentration that induces enough contractility in fibro-
blasts to cause them to round up within 30 min. Alterna-
tively, cells were given a truncated constitutively active ver-
sion of MLCK along with C3 in molar ratios ranging from
1:1 to 7:1. Cells were plated onto coverslips, and their mor-
phology was assessed by F-actin staining. The formation of
tails induced by Y-27632 or C3 was not blocked by either of
these contractility inducing agents (data not shown). To-
gether, our results show that myosin contractility is not suffi-
cient for tail retraction of the migrating monocyte. It is likely
that myosin contractility plays a role in tail retraction, but
our data suggest that an additional mechanism is required.
 
Localized integrin adhesion. 
 
Observation of the migra-
tion of C3-loaded monocytes using time-lapse video micros-
copy suggested that the end of the trailing monocyte tail is
strongly adherent to the endothelial monolayer. Frequently,
the leading edge of an elongated cell rapidly reverses direc-
tion and returns to the original point of adhesion at the end
of the tail. In addition, the trailing tail of the C3-loaded
monocyte occasionally broke off from the main cell body as
it migrated away. These observations of monocyte behavior
led us to further investigate the regulation of adhesion mole-
cules by RhoA. We have shown that inhibition of RhoA by
C3 loading had no effect on overall attachment of mono-
cytes to activated endothelial cells (Fig. 2). However, leuko-
cyte adhesion to endothelial monolayers involves several
 
classes of molecules including integrins, membrane-bound
cytokines, and lectins. We considered the possibility that
RhoA might have no effect on whole cell attachment to the
HUVEC monolayer, but still regulate individual adhesion
molecules. First, we determined if inhibition of p160ROCK
with Y-27632-affected monocyte binding to endothelial
monolayers, as had been shown with C3-loaded monocytes
(Fig. 2). Consistent with results with C3-loaded primary
monocytes, Y-27632 had no significant effect on monocyte
attachment to either resting or activated HUVECs (Fig. 9
A). Next, we assessed the effect of CA ROCK on monocyte
adhesion to activated endothelial monolayers. We did not
observe any significant effect on adhesion between mono-
cytes loaded with CA ROCK compared with GST-loaded
controls (Fig. 9 A).
To determine if RhoA signaling affected adhesion to spe-
cific molecules, we measured adhesion of monocytes to im-
mobilized extracellular domains of ICAM-1 or VCAM, two
key adhesion molecules that mediate leukocyte-endothelial
cell interactions. ICAM-1 is the ligand for 
 
 
 
2 integrins,
whereas VCAM binds to 
 
 
 
4
 
 
 
1. Fig. 9 A shows that treating
cells with Y-27632 increased the number of cells binding to
either ICAM-1 or VCAM by four- to fivefold over a time
course ranging from 5–60 min. The number of cells attached
to these integrin ligands increased slowly over time, with con-
trol cells reaching a maximum at 20 min. Conversely, mono-
cytes loaded with CA ROCK showed reduced adhesion at all
time points, compared with control cells loaded with GST,
to both ICAM-1 and VCAM. To better understand the ef-
fect of p160ROCK on integrin-mediated adhesion of mono-
cytes, the morphology of the adherent cells was monitored
by microscopy. We found that cells treated with Y-27632
Figure 7. Microtubules are not the tar-
get of C3 for tail retraction. (Top) 
Monocytes that were loaded with C3 
and plated for 20 min before the incuba-
tion with 1  M nocodazole for an addi-
tional 20 min. (Bottom) Monocytes that 
were plated on coverslips in the pres-
ence or absence of 3  M taxol for 45 
min before fixation and staining for F-actin 
(red) and tubulin (green). Cells were then 
fixed and stained for F-actin (red) and tu-
bulin (green). Bar, 20  m. 
RhoA in transmigration |
 
 Worthylake et al. 155
 
were markedly more spread, whereas those loaded with CA
ROCK were rounded and resembled the controls (Fig. 9 B).
Because we hypothesized that the effect of RhoA/
p160ROCK on monocyte adhesion was localized to the rear
of the migrating cells, we analyzed the distribution of 
 
 
 
2 in-
tegrins in monocytes cultured on glass coverslips. Migrating
monocytes assume a polarized morphology with a broad
leading edge and more tapered tail region. Using this criteria,
we indicated the rear of the monocytes with arrows in Fig.
10. We found the 
 
 
 
2 integrin localized at the leading edge of
control monocytes. In contrast, we found high levels of 
 
 
 
2
integrin in the unretracted tails of C3-loaded monocytes
(Fig. 10). The ligand for 
 
 
 
2 integrin in these samples is un-
clear, as the monocytes are plated on glass coverslips in the
presence of serum. The 
 
 
 
2 integrin is promiscuous and
binds to charged surfaces, fibrinogen and fibronectin in ad-
dition to the more classical ICAM ligands (Rosen and Gor-
don, 1987; van den Berg et al., 2001; Yakubenko et al.,
2001). Although these experiments showed mislocalization
of 
 
 
 
2 integrin on glass coverslips, the localization of the inte-
grin in monocytes cocultured with endothelial cells remains
to be determined. These results indicated that RhoA signal-
ing was required for the appropriate localization of 
 
 
 
2 inte-
grin to the leading edge in monocytes cultured on coverslips.
Together, the behavior of monocytes observed in the video
microscopy, the adhesion assays, and the integrin localiza-
tion data are consistent with a model in which RhoA and the
p160ROCK signaling pathway are required to downregulate
integrin-mediated adhesion in the rear of the migrating cell.
 
Discussion
 
Interactions between leukocytes and the endothelial lining
of vessel walls are highly responsive to inflammatory signals.
Endothelial cells activated by an underlying infection or in-
jury upregulate expression of adhesion molecules and other
stimulatory molecules to induce leukocyte transmigration to
the site of damage. We designed studies to determine which
step of transmigration required RhoA activity in monocytes.
We found that RhoA was not required for initial attachment
to the endothelium or the subsequent spreading on the en-
dothelium. Interestingly, RhoA was not required for forward
motility of the main cell body or invasion of the endothelial
monolayer. Instead, RhoA activity and its downstream effec-
tor, p160ROCK, were found to be required for retracting
the rear of the migrating monocyte. We propose a model in
which RhoA/p160ROCK is required to downregulate inte-
grin adhesions at the rear of the cells to allow tail retraction,
to allow the monocyte to complete diapedesis.
Cell migration is the result of forward movement followed
by retraction of the rear of the cell. Forward movement of
monocytes is thought to be driven by actin polymerization
at the leading edge (Stossel, 1993). This results in extensions
of filopodia and lamellipodia that are regulated by Cdc42
and Rac1, respectively. As has been previously reported, we
find that inhibition of RhoA by C3 is sufficient to induce
cell protrusion and spreading of rounded leukocytes (Aepfel-
bacher et al., 1996; Allen et al., 1997; Watson et al., 2000).
This is likely due to relief from functional inhibition of endog-
enous Rac1 and Cdc42 proteins by RhoA. Consistent with
this, we find high levels of Rac1 and Cdc42 activity even in
resting cells (data not shown). Previous studies have shown
that there is an optimal level of RhoA-dependent adhesion
needed to drive cell migration (Nobes and Hall, 1999). Cells
need a certain level of adhesiveness to generate traction and
move forward; however, too much adhesiveness prevents cell
migration (Huttenlocher et al., 1996; Palecek et al., 1997).
Our data indicate that monocytes have sufficient adhesion
to drive forward movement in the absence of RhoA activity.
Protrusive membranes are stabilized through small clusters
of molecules, called focal complexes, that tether the trans-
membrane adhesion molecules to the cytoskeleton. Forma-
tion of focal complexes at the leading edge of migrating
macrophages or at sites of fibroblast protrusion requires
Rac1 and Cdc42, but not RhoA (Huttenlocher et al., 1996;
Palecek et al., 1997; Rottner et al., 1999). The adhesiveness
required for forward movement of monocytes may be pro-
vided by focal complexes that are independent of RhoA.
Typically, fibroblasts have slower retraction of the tail rela-
tive to forward protrusion, yielding a triangular-shaped mi-
grating cell. Keratocytes have fast forward movement and
equally fast tail retraction, such that their morphology is
crescent shaped during migration (Lauffenburger and Hor-
witz, 1996). Leukocytes are reported to move with interme-
diate speeds, compared with fibroblasts and keratocytes, and
migrating cells often display a triangular morphology. Our
time-lapse video microscopy analysis clearly shows that C3-
loaded monocytes have robust protrusive activity and for-
ward movement but are deficient in retraction of the rear of
the cell. Thus, inhibition of RhoA or p160ROCK results in
Figure 8. The contractility inhibitors, BDM and ML-7, do not in-
duce tail formation. Monocytes were plated in serum containing 
media in the presence of various contractility inhibitors. After 45 
min, cells were fixed and stained for F-actin to reveal cell morphol-
ogy. (A) Control; (B) 20 mM BDM; (C) 20  M ML-7; (D) 10  M 
Y-27632. Bar, 20  m. 
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the accumulation of cells with long tails. This is consistent
with a previous study of prostate cancer cells showing the ac-
cumulation of unretracted tails when treated with Y-27632
(Somlyo et al., 2000). In addition, our data show that RhoA/
p160ROCK-mediated tail retraction is critical during the
physiological process of monocyte extravasation. To success-
fully migrate, cells must coordinate forward movement with
release of the rear of the cell. In our transendothelial migra-
tion system, monocytes that invade the endothelial mono-
layer require RhoA activity to couple rear retraction with the
forward movement to complete diapedesis.
An important target of RhoA and p160ROCK signaling is
myosin-generated contractility. RhoA regulates myosin ac-
tivity, and many models of cell migration invoke myosin-
driven contractility in bringing up the rear of the cell. Con-
sistent with this idea, studies with neutrophils have impli-
cated myosin-based contractility in uropod retraction at the
rear of the cell (Eddy et al., 2000). Although we did not ob-
serve a morphological structure resembling a uropod in our
monocyte culture system, we reasoned that myosin contrac-
tility could be involved in retracting the tail of migrating
monocytes. We tested whether inhibition of myosin con-
tractility could inhibit tail retraction in our system with
multiple contractility blocking compounds. Unexpectedly,
we found that this was not sufficient to induce tail forma-
tion. In addition, we attempted to block the tails formed by
C3 or Y-27632 with stimulators of contractility, but these
agents were unable to block tail formation. We believe that
myosin-generated force does play a role in retracting the rear
of migrating monocytes, but find that inhibiting contractil-
ity is not sufficient for formation of the long trailing tails ob-
served when RhoA activity was blocked. We sought to find
an additional process regulated by RhoA and p160ROCK
that contributed to tail retraction.
Observation of monocyte migration using time-lapse
video microscopy suggests that the end of the trailing mono-
cyte tail is strongly adherent to the endothelial monolayer.
In addition, a role for turnover of adhesions in the tail of
leukocytes had been previously suggested by experiments
showing that calcium-regulated transport of integrins from
the rear of the cell to the front was important for rear retrac-
tion (Lawson and Maxfield, 1995; Pierini et al., 2000). In fi-
broblasts, it is well established that RhoA promotes the for-
mation of integrin-containing focal adhesions. However, the
role of RhoA in integrin adhesion in leukocytes is unclear.
Although we did not detect any effect of RhoA activity on
Figure 9. p160ROCK increases adhe-
sion of monocytes to individual adhesion 
molecules. (A) For adhesion to activated 
endothelial monolayers, monocytes 
were fluorescently labeled, after treat-
ment with Y-27632 or loading with CA 
ROCK or GST. Adhesion was detected 
by fluorimetry. For adhesion to ICAM-1 
and VCAM, monocytes were added to 
plates coated with the adhesion mole-
cules in the presence or absence of 
Y-27632, or after loading with CA ROCK 
or GST. At times ranging 5–60 min, cells 
were fixed and stained with Coomassie 
blue, followed by microscopic analysis. 
The data represent the number of cells 
counted in 10 separate fields from tripli-
cate wells in a representative experiment. 
(B) The morphology of the adherent cells 
was recorded from the cell samples de-
scribed in A. Y-27632 dramatically in-
creased cell spreading on both ICAM-1 
and VCAM substrates, whereas CA 
ROCK had little affect. 
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adhesion to activated endothelial cells, we considered that
adhesion to specific molecules could be regulated by RhoA.
We found that inhibition of p160ROCK increased, whereas
constitutively active ROCK decreased the number of mono-
cytes adhered to immobilized ICAM-1 and VCAM, consis-
tent with the notion that regulation of integrin adhesion is
an important target for RhoA signaling. The dramatic po-
tentiation of cell attachment to these integrin ligands by
Y-27632 occurred over a slow time course, and was accom-
panied by markedly increased spreading. Together, these re-
sults suggested that the avidity of the integrin adhesion was
increased in the absence of p160ROCK activity. Thus, the
function of RhoA signaling in leukocytes may be fundamen-
tally different than in fibroblasts. The effect of p160ROCK
appeared not to be confined to particular integrins and its
activity may result in a global effect such as promoting in-
hibitory interactions between integrins and the cytoskeleton,
or promoting transport of integrins from the rear of the cell.
Previous studies have shown that calcium-dependent tail
retraction in neutrophils involved oriented recycling of inte-
grins from the tail to the leading edge (Pierini et al., 2000).
We found that integrin localization to the leading edge of mi-
grating monocytes was also regulated by RhoA activity. We
propose that as the cell body moves over integrin adhesions
formed at the leading edge, the adhesive structures would
then be located towards the rear of the cell where RhoA/
p160ROCK signaling is required to induce turnover of the
adhesions, and result in recycling of the integrin to the front
of the cell. In an analysis of directional migration of an adher-
ent macrophage cell line, inhibition of RhoA was found to
abolish chemotaxis towards a CSF-1 gradient, although ran-
dom movement was not completely inhibited (Allen et al.,
1998). This is consistent with our observations that C3-
loaded cells often have significant protrusive activity at both
ends of the elongated cell, and frequently the cell body re-
turns to the site of attachment at the end of the tail. An in-
triguing possibility is that unreleased adhesive contacts at the
rear of the cell generate signals promoting forward movement
that are in competition with similar signals at the leading edge
of the main cell body. Thus, dissolution of adhesions in the
tail may be required to allow persistent directional migration.
Our study of RhoA function in highly motile primary
monocytes highlights a previously unappreciated role for
RhoA in negative regulation of integrin-mediated adhesions
at the rear of the migrating cell. There is considerable interest
in targeting RhoA signaling pathways for pharmacological
modulation of atheroscleorotic lesions and metastasis. The use
of the p160ROCK inhibitor, Y-27632, is being investigated
as a modulator of inflammation and tumor metastasis in ani-
mal models (del Peso et al., 1997; Itoh et al., 1999; Miyata et
al., 2000). An effect of Y-27632 on monocyte extravasation
during formation of atherosclerotic lesions is unclear, but it
has been reported that p160ROCK is important for invasive
protrusions in tumor cell systems. In contrast, we find that
monocytes appear to have extensive protrusive capabilities
that are particularly active when RhoA is inhibited. We pro-
pose that an alternative mechanism for Y-27632 in modulat-
ing of leukocyte extravasation is the uncoupling of rear retrac-
tion from invasion of the endothelial lining of the vessel wall.
 
Materials and methods
 
Cell culture
 
HUVECs pooled from several donors were purchased from Clonetics and
grown in Clonetics EGM-2 media according to manufacturer’s instructions
(BioWhittaker). HUVECs were routinely used between passage 2–6. Ma-
ture HUVEC monolayers were formed by seeding at a confluent density of
Figure 10. C3-loaded monocytes mislo-
calize  2 integrin to the unretracted tail. 
Monocytes were loaded with GST or C3 
and plated on coverslips in serum-con-
taining media for 45 min before fixation 
and immunofluorescent localization of 
 2 integrin. The  2 integrin was concen-
trated at the leading edge of polarized 
GST control cells, whereas its expression 
was reduced in regions where the cell 
was retracting (arrows). In contrast, high 
levels of  2 integrin are visible in the un-
retracted tails of C3-loaded monocytes. 
Bars, 20  m. 
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7.5
 
   
 
10
 
4
 
 cells/cm
 
2
 
 on surfaces coated with 10 
 
 
 
g/ml Matrigel (Collabora-
tive BioMedical Products,) and culturing for 2–3 d before addition of 600
pg/ml IL-1 (R&D Systems) overnight. Conditions were optimized by moni-
toring immunolocalization of 
 
 
 
-catenin at the cell–cell junctions and the
presence of few actin stress fibers.
Human monocytes were isolated from healthy volunteer donors as de-
scribed previously by centrifugation through Ficoll/Histopaque 1077
(Sigma-Aldrich) and a Percoll (Amersham Pharmacia Biotech) step gradi-
ent (Lofquist et al., 1995; Harkin and Hay, 1996). Isolated monocytes were
resuspended in serum free RPMI 1640 (Life Technologies) and used within
1–3 h after isolation. Purity of the cell population was monitored by mor-
phological analysis and routinely found to contain 80–90% monocytes.
The THP-1 monoctyic cell line was cultured in RPMI 1640 supplemented
with 10% fetal bovine serum (Life Technologies) and antibiotics.
 
Monocyte and endothelial cell cocultures
 
For transmigration assays, 6.5-mm transwell inserts (Corning Costar Corp.)
with 8.0-
 
 
 
m pores were used to culture HUVEC monolayers as described
above. To prevent HUVECs from migrating through the membrane, mono-
layers were established in the inserts without media in the lower chamber.
Just before the assay, the monolayers were rinsed with serum-free RPMI
1640 and 10
 
5
 
 primary monocytes, or THP-1 cells were added to the upper
chamber. At the same time, a coverslip and 600 
 
 
 
l of serum free RPMI
1640, supplemented with 100 ng/ml MCP-1 (R&D Systems) when appro-
priate, were added to the lower chamber. Transmigration proceeded for
1 h in the case of primary monocytes and 3 h for the THP-1 cells. Transmi-
gration was stopped by removing the transwell insert. To promote adhe-
sion of THP-1 cells to the coverslip, 100 ng/ml PMA (Sigma-Aldrich) was
added to the lower chamber for 30 min. Coverslips were fixed with 3.7%
formaldehyde and stained with crystal violet dye for 10 min before rinsing
with water and mounting on a slide for counting by microscopy. Cells per
field were counted from 15 independent fields from triplicate transwells
for each experiment.
For time-lapse video microscopy, HUVEC monolayers were cultured on
4-chamber chamber slides (Fisher Scientific). At the time of the assay, the
chambers were removed, and a 0.5-mm deep perfusion chamber (Molecu-
lar Probes) was placed over the endothelial cells. 0.25 ml of 2.5 
 
  
 
10
 
5
 
cells per ml of monocytes in serum-free RPMI 1640 were added to the per-
fusion. Monocyte motility was assessed using time-lapse microscopy 20
s/frame with a 40
 
 
 
 phase objective and the NIH Image Movie program. Im-
ages were recorded every 20 s for 25 min, beginning 15 min after the addi-
tion of monocytes. The video clips were processed into QuickTime movies
using Adobe
 
®
 
 PhotoReady software.
Monocyte and endothelial coculture samples for immunofluorescence
analysis were prepared by culturing HUVECs on round coverslips placed
in a 24-well plate. 10
 
5
 
 monocytes were added to the well containing the
HUVEC monolayer in serum-free RPMI 1640. Cells were fixed with 3.7%
formaldehyde and processed for immunofluorescence as indicated.
 
Electroporation of monocytes
 
2
 
   
 
10
 
6
 
 monocytes were resuspended in 400 
 
 
 
l of serum-free RPMI 1640
and placed in a 0.4-cm cuvette (Bio-Rad Laboratories) along with 100 
 
 
 
g
purified GST fusion protein. Cells were subjected to 450 kV at 25  F,
yielding a typical time constant of 0.8 ms in a Bio-Rad Gene Pulser™. For
experiments where two proteins were introduced simulataneously, 33  g
of C3 and 66  g of GST or CA ROCK was used. Electroporated cells were
then placed on ice in polypropylene tubes with an additional 600  l of se-
rum-free RPMI 1640 supplemented with 10  g/ml polymyxin B (Sigma-
Aldrich) and allowed to recover for 15 min. Cells were then washed with se-
rum-free RPMI 1640 to remove excess protein before use in the various
assays. Several parameters were measured to ensure the electroporation
procedure was not significantly damaging the cells. Viability was assessed by
Trypan blue exclusion (Sigma-Aldrich) and routinely found to be  90% vi-
able. Integrity of the cytoskeleton was assessed by comparison of actin and
tubulin structures in untreated and GST-loaded samples, and was found to
be unaffected by the procedure. Additionally, we found that the fraction of
cells that received the electroporated protein was 80–90% as assessed by
uptake of Texas red–labeled dextran by electroporation, or by scoring the
number of C3 cells for the C3 phenotype described in this paper. In all ex-
periments analyzing the affects of C3 on monocytes, GST-electroporated
cells were used as controls for any unforeseen affects arising from the elec-
troporation procedure.
Immunofluorescence
Monoctye and endothelial coculture samples were obtained and fixed as
described above and permeabilized with 0.5% Triton X-100 for 10 min
when required. Monocyte samples were prepared by adding 10
5 cells to
wells of a 24-well plate containing a glass coverslip for 45 min in
RPMI1640 supplemented with 10% autologous serum from donor blood.
Cells were fixed with 3.7% formaldehyde and permeabilized with 0.5%
Triton X-100 for 10 min in most cases. For costaining for actin and tubulin,
cells were fixed with 3.7% formaldehyde/0.2% glutaraldehyde/0.1% Triton
X-100 in CB buffer (10 mM MES, 150 mM NaCl, 5 mM EGTA, 5 mM
MgCl2, and 25 mM glucose). Actin staining was performed by incubation
with 1:250 dilution of Texas red phalloidin (Molecular Probes). Tubulin
staining was performed by incubation with 1:250 dilution of  -tubulin anti-
body (Sigma-Aldrich) followed by FITC-anti–mouse F(ab)2 (Jackson Immu-
noResearch Laboratories) at 1:50 dilution. Staining for  2 integrin was ac-
complished by incubation with a 1:50 dilution of FITC-conjugated antibody
(Chemicon). Fluorescent labeling of monocytes was achieved by incubating
monocytes with 1:2,000 dilution of Cell Tracker green (CMFDA) from Mo-
lecular Probes for 15 min, followed by washing to remove free dye. Sam-
ples were analyzed with a ZEISS Axoiophot microscope using 63  or
100  objectives, and digital images were obtained with Metamorph imag-
ing software (Universal Imaging Corp.) and a MicroMAX 5-MHz cooled
charge-coupled device camera (Princeton Instruments). The sizes of 24-bit
presentation images were adjusted using Adobe
® Photoshop software™.
Adhesion assays
Adhesion to HUVECs grown in 96-well plates was assessed by labeling
monocytes with Cell Tracker green (above) and adding 10
5 monocytes per
well for 15 min. Wells were washed with PBS and fixed with 3.7% formal-
dehyde, followed by the addition of PBS. Fluorescence was measured us-
ing a Fluostar fluorimeter and manufacturer’s software (BMG LabTechnolo-
gies). Wells containing only HUVECs were used to determine background
fluorescence levels. Triplicate wells were used for each experiment.
Soluble ICAM-1 and VCAM (R&D Systems) were coated on 96-well
plates Immulon 2HB plates (Fisher Scientific) at a concentration of 10  g/
ml for 2 h at 37 C, followed by blocking with 1% BSA for 1 h at 37 C. 5  
10
4 monocytes were added to triplicate wells and allowed to adhere in the
presence of absence of 10  M Y-27632. Cells were allowed to adhere for
a time course ranging from 5 to 60 min and were then gently washed with
PBS 2 times, fixed with 3.7% formaldehyde, and stained for 10 min with
Coomassie blue. Stained cells were washed with water and air dried be-
fore analyzing by microscopy. The number of adherent cell per field were
counted at a magnification of 25  by light microscopy. The morphology
of the adherent cells was recorded using a Nikon COOLPIX 950 camera.
Wells coated with just 1% BSA were used for background measurements.
Pharmacological reagents and recombinant protein preparation
The p160ROCK inhibitor, Y-27632, was provided by Welfide Corporation.
For samples only containing monocytes, cells were plated in the presence
of 10  M Y-27632. For monocyte and endothelial cell cocultures, cells
were pretreated with 10  M Y-27632 for 15 min and then washed and re-
suspended in 1  M Y-27632 to minimize the affects of the inhibitor on the
endothelial cells. In addition, coculture experiments with the Y-27632
were allowed to proceed for 15–20 min to further minimize the affects of
the inhibitor on monolayer integrity. No obvious effects on monolayer in-
tegrity were observed with this procedure.
The contractility inhibitor, BDM (Sigma-Aldrich), was used at concen-
trations ranging 0.1–20 mM. The MLCK inhibitor, ML-7 (Sigma-Aldrich),
was used at 20  M. Taxol (Sigma-Aldrich) was used at 3  M. Nocodazole
(Sigma-Aldrich) was used at a concentration of 1  M. In all cases ranges of
inhibitors were tried, and the optimal concentration chosen for the experi-
ments is given above.
A constitutively active truncation mutant of p160ROCK was a gift from
Dr. K. Kaibuchi (Nagoya University, Aichi, Japan). To obtain the recombi-
nant protein, we subcloned the p160ROCK fragment into a pET28(c) vec-
tor (Novagen) using BamHI restriction digest. The His(6) fusion protein was
isolated using manufacturer’s instructions (Novagen).
The purified, constitutively active MLCK was a gift from Dr. Primal de
Lanorelle (University of Illinois at Chicago, Chicago, IL), and 25  g total
protein was introduced into cells by lipid transfer reagent LT-1 (Panvera).
In these experiments, comparisons were made to monocytes loaded with
GST or C3 by the same technique. The phenotype of C3-loaded cells by
lipid transfer was comparable to that observed with electroporation.
The RBD fragment from Rhotekin construct has been previously de-
scribed (Arthur et al., 2000). GST-tagged recombinant proteins (GST alone,
C3, and RBD) were isolated from BL-21 bacteria using the manufacturer’s
protocol for GST fusion proteins with minor modifications (Amersham
Pharmacia Biotech). The glutathione–Sepharose beads were washed ex-
tensively with large volumes of PBS to remove contaminants. The fusionRhoA in transmigration | Worthylake et al. 159
proteins were eluted with PBS containing 20 mM reduced glutathione ad-
justed to pH 8.0 and directly used for electroporation. Attempts to dialyze
the samples or further purify the samples resulted in poor viability of elec-
troporated monocytes. The lipopolysaccharide (LPS) content of the protein
preparations was assessed by the Limulus test and was found to be present
at low levels. To combat complications arising from LPS contamination of
protein samples, we treated the electroporated cells with polymixin B (an
inhibitor of LPS signaling). In addition, the experiments were carefully con-
trolled by including cells loaded with GST alone so that any differences in
results with GST and C3 or RBD are not due to LPS contamination.
Online supplemental material
Supplemental video material is available at http://www.jcb.org/cgi/content/
full/200103048/DC1. Either GST- (Video 1) or C3-loaded (Video 2) mono-
cytes were plated on IL-1–activated HUVEC monolayers cultured on
glass slides. Images were recorded using NIH Image Movie software with a
40  phase objective every 20 s. Videos were compiled from 50 frames, or
16.6 min, in Adobe
® ImageReady software. In Video 1 with GST-loaded
monocytes, three cells undergo diapedesis in the order indicated by the
numerical label. Note that the cells were round and refractile before dia-
pedesis and become well spread underneath the monolayer. In Video 2
with C3-loaded monocytes, four monocytes representing four commonly
observed behaviors, have been labeled 1–4. Cell 1 began as a rounded re-
fractile cell that crawls forward along the endothelial monolayer, but does
not retract the tail and becomes elongated. Cell 2 began as an elongated
cell with a leading edge and a trailing tail. Note that the tail of this mono-
cyte was very protrusive. Eventually, the main cell body reverses direction
and returns to the original point of attachment at the tip of the tail. Cell 3
began with a long tail that quickly bifurcated with two refractile rounded
regions separated by a flat area. Protrusive activity was visible at both ends
of the cell throughout the course of the video. Our interpretation is that this
cell invaded the monolayer, did not retract the tail, and the front of the cell
returned to the top side of the monolayer, resulting in a U-shaped cell. Cell
4 began with part of the cell spread under the monolayer and part of the
cell as a refractile round region on top of the HUVECs. Throughout the
course of the video, the leading edge of the cell was highly protrusive, yet
the tail did not move through the monolayer to complete diapedesis.
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